InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Cole Jason, Chief Operating and. Insider active across 1 company, notably bluebird bio, Inc.. In total, 7 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €124k. History available since 3 May 2021. The latest transaction was disclosed on 19 August 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Cole Jason
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
14,194 shares@ US$5.528656.8% of flowCommon StockSEC:0001562180-22-006290:0
7,448 shares@ US$4.391423.3% of flowCommon StockSEC:0001562180-22-005941:0
25,000 shares0Common StockSEC:0001562180-22-001083:0
1,584 shares@ US$9.402248.3% of flowCommon StockSEC:0001562180-22-000443:0
1,539 shares0Common StockSEC:0001628280-21-023652:0
32,266 shares0Common StockSEC:0001562180-21-005171:0
38 shares@ US$30.15110.8% of flowCommon StockSEC:0001562180-21-003230:0
7 of 7 declarations
About Cole Jason
Jason Cole is Chief Operating Officer and Chief Business Officer at bluebird bio, Inc. He plays a vital role in managing the operations and business development of the company, which focuses on gene therapies.
